Search in:

Advanced search

International Journal of Nephrology and Renovascular Disease Volume 7, 2014 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease

Adrian R Levy1 Department of Community Health and Epidemiology, Dalhousie University, Halifax, NS, Canada;2 Oxford Outcomes Ltd, Vancouver, BC, CanadaCorrespondence[email protected]

Robert M Perkins3 Center for Health Research and Division of Nephrology, Geisinger Health System, Danville, PA, USA

Karissa M Johnston2 Oxford Outcomes Ltd, Vancouver, BC, Canada

Sean D Sullivan4 School of Pharmacy, University of Washington, Seattle, WA, USA

Vipan C Sood5 Mitsubishi Tanabe Pharma America, Jersey City, NJ, USA

Wendy Agnese5 Mitsubishi Tanabe Pharma America, Jersey City, NJ, USA

Mark A Schnitzler6 Departments of Internal Medicine and Community Health, Saint Louis University, St Louis, MO, USA

show all

Pages 271-280 | Published online: 03 Jul 2014

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

WeinsteinMCToyELSandbergEAModeling for health care and other policy decisions: uses, roles, and validityValue Health20014534836111705125
PubMedGoogle Scholar
NaimarkDKrahnMDNaglieGRedelmeierDADetskyASPrimer on medical decision analysis: Part 5 – Working with Markov processesMed Decis Making19971721521599107610
PubMed Web of Science ®Google Scholar
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work GroupKDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)Kidney Int Suppl2009113S113019644521
PubMedGoogle Scholar
TangriNStevensLAGriffithJA predictive model for progression of chronic kidney disease to kidney failureJAMA2011305151553155921482743
PubMed Web of Science ®Google Scholar
HovindPRossingPTarnowLSmidtUMParvingHHProgression of diabetic nephropathyKidney Int200159270270911168952
PubMed Web of Science ®Google Scholar
SilveiroSPFriedmanRde AzevedoMJCananiLHGrossJLFive-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patientsDiabetes Care19961921711748718441
PubMed Web of Science ®Google Scholar
HunsickerLGAdlerSCaggiulaAPredictors of the progression of renal disease in the Modification of Diet in Renal Disease StudyKidney Int1997516190819199186882
PubMed Web of Science ®Google Scholar
BriggsAHHandling uncertainty in cost-effectiveness modelsPharmacoeconomics200017547950010977389
PubMed Web of Science ®Google Scholar
EddyDMHollingworthWCaroJJTsevatJMcDonaldKMWongJBModel transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–7Value Health201215684385022999134
PubMed Web of Science ®Google Scholar
TorranceGWFurlongWFeenyDHealth utility estimationExpert Rev Pharmacoecon Outcomes Res2002229910819807322
PubMedGoogle Scholar
GorodetskayaIZeniosSMcCullochCEHealth-related quality of life and estimates of utility in chronic kidney disease 1Kidney Int20056862801280816316356
PubMed Web of Science ®Google Scholar
BassEBWillsSFinkNEHow strong are patients’ preferences in choices between dialysis modalities and doses?Am J Kidney Dis200444469570515384021
PubMed Web of Science ®Google Scholar
CollinsAJFoleyRNHerzogCUS Renal Data System 2010 Annual Data ReportAm J Kidney Dis2011571 Suppl 1A8e1e52621184928
PubMed Web of Science ®Google Scholar
CollinsAJFoleyRNHerzogCUS Renal Data System 2011 Annual Data ReportAm J Kidney Dis2012591 Suppl 1A7e1e42022177944
PubMed Web of Science ®Google Scholar
PerkinsRMBucaloiuIDKirchnerHLAshouianNHartleJEYahyaTGFR decline and mortality risk among patients with chronic kidney diseaseClin J Am Soc Nephrol2011681879188621685022
PubMed Web of Science ®Google Scholar
SchellJODa Silva-GaneMGermainMJRecent insights into life expectancy with and without dialysisCurr Opin Nephrol Hypertens201322218519223340216
PubMed Web of Science ®Google Scholar
HoefieldRAKalraPABakerPFactors associated with kidney disease progression and mortality in a referred CKD populationAm J Kidney Dis20105661072108120692750
PubMed Web of Science ®Google Scholar
StevensLAGreeneTLeveyASSurrogate end points for clinical trials of kidney disease progressionClin J Am Soc Nephrol20061487488417699300
PubMed Web of Science ®Google Scholar
WinkelmayerWCWeinsteinMCMittlemanMAGlynnRJPliskinJSHealth economic evaluations: the special case of end-stage renal disease treatmentMed Decis Making200222541743012365484
PubMed Web of Science ®Google Scholar
LeeCPChertowGMZeniosSAAn empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standardValue Health2009121808719911442
PubMed Web of Science ®Google Scholar
HoergerTJWittenbornJSSegelJEA health policy model of CKD: 1. Model construction, assumptions, and validation of health consequencesAm J Kidney Dis201055345246220116911
PubMed Web of Science ®Google Scholar
HoergerTJWittenbornJSSegelJEA health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screeningAm J Kidney Dis201055346347320116910
PubMed Web of Science ®Google Scholar
AgarwalRBunayeZBekeleDMLightRPCompeting risk factor analysis of end-stage renal disease and mortality in chronic kidney diseaseAm J Nephrol200828456957518239383
PubMed Web of Science ®Google Scholar
DetskyASNaglieGKrahnMDNaimarkDRedelmeierDAPrimer on medical decision analysis: Part 1 – Getting startedMed Decis Making19971721231259107606
PubMed Web of Science ®Google Scholar
National Kidney Foundation and the US Food and Drug AdministrationGFR Decline as an Endpoint for Clinical Trials in CKD Available from: https://www.kidney.org/professionals/research/pdf/EndpointsConfRoster.pdfAccessed February 22, 2014
Google Scholar
BambergerMMooreNLechatPHow to improve the clinical development paradigm and its division into phases I, II and IIITherapie201166433133421851796
PubMed Web of Science ®Google Scholar
SculpherMDrummondMBuxtonMThe iterative use of economic evaluation as part of the process of health technology assessmentJ Health Serv Res Policy199721263010180650
PubMedGoogle Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date